These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 19710582)

  • 1. Reduced physician claims for otitis media after implementation of pneumococcal conjugate vaccine program in the province of Quebec, Canada.
    Wals PD; Carbon M; Sévin E; Deceuninck G; Ouakki M
    Pediatr Infect Dis J; 2009 Sep; 28(9):e271-5. PubMed ID: 19710582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of conjugate pneumococcal vaccination in Singapore: comparing estimates for 7-valent, 10-valent, and 13-valent vaccines.
    Tyo KR; Rosen MM; Zeng W; Yap M; Pwee KH; Ang LW; Shepard DS
    Vaccine; 2011 Sep; 29(38):6686-94. PubMed ID: 21745516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of the 7-valent pneumococcal conjugate vaccine in children with sickle cell disease in the first decade of life.
    Adamkiewicz TV; Silk BJ; Howgate J; Baughman W; Strayhorn G; Sullivan K; Farley MM
    Pediatrics; 2008 Mar; 121(3):562-9. PubMed ID: 18310206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeling the impact of a new vaccine on pneumococcal and nontypable Haemophilus influenzae diseases: a new simulation model.
    De Wals P; Black S; Borrow R; Pearce D
    Clin Ther; 2009 Oct; 31(10):2152-69. PubMed ID: 19922887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of a 2+1 dose schedule pneumococcal conjugate vaccination programme on invasive pneumococcal disease among children in Norway.
    Vestrheim DF; Løvoll O; Aaberge IS; Caugant DA; Høiby EA; Bakke H; Bergsaker MR
    Vaccine; 2008 Jun; 26(26):3277-81. PubMed ID: 18456376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 7-Valent pneumococcal conjugate vaccine and otitis media: effectiveness of a 2-dose versus 3-dose primary series.
    Stoecker C; Hampton LM; Moore MR
    Vaccine; 2012 Sep; 30(44):6256-62. PubMed ID: 22906725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of pneumococcal conjugate vaccine using a 2+1 infant schedule in Quebec, Canada.
    Deceuninck G; De Wals P; Boulianne N; De Serres G
    Pediatr Infect Dis J; 2010 Jun; 29(6):546-9. PubMed ID: 20125062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population-based impact of pneumococcal conjugate vaccine in young children.
    Poehling KA; Lafleur BJ; Szilagyi PG; Edwards KM; Mitchel E; Barth R; Schwartz B; Griffin MR
    Pediatrics; 2004 Sep; 114(3):755-61. PubMed ID: 15342850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Streptococcus pneumoniae-related illnesses in young children: secular trends and regional variation.
    Poehling KA; Szilagyi PG; Edwards K; Mitchel E; Barth R; Hughes H; Lafleur B; Schaffer SJ; Schwartz B; Griffin MR
    Pediatr Infect Dis J; 2003 May; 22(5):413-8. PubMed ID: 12792380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of pneumococcal conjugate vaccine on rates of myringotomy with ventilation tube insertion in Australia.
    Jardine A; Menzies RI; Deeks SL; Patel MS; McIntyre PB
    Pediatr Infect Dis J; 2009 Sep; 28(9):761-5. PubMed ID: 19546840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pneumonia after implementation of the pneumococcal conjugate vaccine program in the province of Quebec, Canada.
    De Wals P; Robin E; Fortin E; Thibeault R; Ouakki M; Douville-Fradet M
    Pediatr Infect Dis J; 2008 Nov; 27(11):963-8. PubMed ID: 18845982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Herd immunity and pneumococcal conjugate vaccine: a quantitative model.
    Haber M; Barskey A; Baughman W; Barker L; Whitney CG; Shaw KM; Orenstein W; Stephens DS
    Vaccine; 2007 Jul; 25(29):5390-8. PubMed ID: 17583392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pneumococcal conjugate vaccination does not induce a persisting mucosal IgA response in children with recurrent acute otitis media.
    Bogaert D; Veenhoven RH; Ramdin R; Luijendijk IH; Rijkers GT; Sanders EA; de Groot R; Hermans PW
    Vaccine; 2005 Apr; 23(20):2607-13. PubMed ID: 15780443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Invasive pneumococcal diseases in birth cohorts vaccinated with PCV-7 and/or PHiD-CV in the province of Quebec, Canada.
    De Wals P; Lefebvre B; Defay F; Deceuninck G; Boulianne N
    Vaccine; 2012 Oct; 30(45):6416-20. PubMed ID: 22921290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of 2+1 pneumococcal conjugate vaccine program in the province of Quebec, Canada.
    De Wals P; Lefebvre B; Markowski F; Deceuninck G; Defay F; Douville-Fradet M; Landry M
    Vaccine; 2014 Mar; 32(13):1501-6. PubMed ID: 24486346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Epidemiological features of invasive pneumococcal disease before and after the introduction of pneumococcal conjugate vaccine in Gran Canaria (Canary Islands)].
    Artiles F; Horcajada I; Cañas AM; Alamo I; Bordes A; González A; Santana M; Lafarga B
    Enferm Infecc Microbiol Clin; 2009 Jan; 27(1):14-21. PubMed ID: 19217998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surveillance for invasive pneumococcal disease during 2000-2005 in a population of children who received 7-valent pneumococcal conjugate vaccine.
    Black S; France EK; Isaacman D; Bracken L; Lewis E; Hansen J; Fireman B; Austrian R; Graepel J; Gray S; Klein NP
    Pediatr Infect Dis J; 2007 Sep; 26(9):771-7. PubMed ID: 17721369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimated effect of pneumococcal conjugate vaccination on invasive pneumococcal disease and associated mortality, Denmark 2000-2005.
    Harboe ZB; Valentiner-Branth P; Benfield TL; Christensen JJ; Hjuler T; Kaltoft M; Krogfelt KA; Lambertsen L; Konradsen HB
    Vaccine; 2008 Jul; 26(29-30):3765-71. PubMed ID: 18513840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of pneumococcal conjugate vaccine and of reduction of antibiotic use on nasopharyngeal carriage of nonsusceptible pneumococci in children with acute otitis media.
    Cohen R; Levy C; de La Rocque F; Gelbert N; Wollner A; Fritzell B; Bonnet E; Tetelboum R; Varon E
    Pediatr Infect Dis J; 2006 Nov; 25(11):1001-7. PubMed ID: 17072121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of a 3-dose pneumococcal conjugate vaccine program in the province of Quebec, Canada.
    Poirier B; De Wals P; Petit G; Erickson LJ; Pépin J
    Vaccine; 2009 Nov; 27(50):7105-9. PubMed ID: 19786137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.